Nasdaq

20 stories about Nasdaq
נאסדק

Kornit Digital Aims to Raise $130 Million in Public Offering

12.06.19|Micky Grunfeld
The Nasdaq-listed company has chosen Citigroup, Goldman Sachs, and Barclays as the bookrunners
מימין שי וינינגר ו  דניאל שרייבר מייסדי Lemonade למונייד

Online Insurer Lemonade Heading for New York IPO

04.06.19|Golan Hazani
The SoftBank-backed company has hired JP Morgan as the underwriter and is looking to go public within six months, according to two people familiar with the matter
נאסדק

Medical Aesthetic Devices Manufacturer InMode Gearing Up for Nasdaq IPO

03.06.19|Golan Hazani
InMode develops devices that use radio-frequency energy technology, capable of penetrating subdermal fat
נאסדק

Medtech Company G Medical Innovation Files for Nasdaq IPO

20.05.19|CTech
The Israel-based, Sidney-listed company is aiming to raise $15 million under the ticker GMVD
בריינסוויי Brainsway

Brainsway Completes Nasdaq IPO With $27.5 Million

23.04.19|CTech
The Israeli company develops headsets that use magnetic stimulation to treat brain disorders
נאסדק

Brainsway to Start Trading on Nasdaq Wednesday

17.04.19|Lilach Baumer
The Israeli medical device company expects to raise $27.5 million in its initial public offering
נאסד"ק וול סטריט

InterCure Subsidiary Canndoc Files Confidential Nasdaq Prospectus

15.04.19|Tzally Greenberg
InterCure, chaired by former Israeli prime minister Ehud Barak, has previously announced its IPO intentions. Cannadoc is one of nine licensed cannabis growers in Israel
ועידת התחזיות 2019 בצלאל מכליס נשיא ו מנכ"ל אלביט

Elbit Intends to Raise $186 in Private Offering

09.04.19|Golan Hazani
The defense contractor announced it has obtained the commitment of several Israeli institutional investors to acquire 1.4 million shares at a price of $132 per share
נאסד"ק וול סטריט

Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering

09.04.19|CTech
Chiasma develops octreotide capsules for the treatment of acromegaly, a rare, chronic disease typically caused by a benign tumor of the pituitary gland
הבורסה לניירות ערך רחוב אחוזת בית תל אביב

Email Protection Company Cyren to Delist from Tel Aviv Exchange on Wednesday

04.04.19|Lilach Baumer
Cyren was founded in Israel in 1991 as an email services provider and changed direction after its 1999 Nasdaq IPO
מונית של גט טקסי Gatt

Ahead of Potential IPO, Gett Changes Chief Financial Officer

31.03.19|Meir Orbach
Aliaksei Aneichyk, until recently a senior executive at Credit Suisse, will be stepping in following Tal Brener’s resignation
נאסדק

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19|Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”
הבורסה לניירות ערך רחוב אחוזת בית תל אביב

Anchiano Therapeutics Schedules TASE Delisting

14.03.19|Lilach Baumer
Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer
יו" סטרטסיס והמנכ"ל בפועל אלחנן יגלום

U.S. Government Shutdown Tanked Fourth Quarter Sales, Says Stratasys

10.03.19|Hezi Sternlicht
Stratasys manufacturers 3D printers and production systems for several industries, including aerospace, automotive, healthcare, and consumer products
נאסדק

Top Image Filing Reveals Kofax's Initial Offer Was Higher

05.03.19|CTech
In February, Nasdaq-listed content processing solutions company Top Image announced Kofax agreed to acquire it for $16 million
איתמר מדיקל WatchPAT

Itamar Medical Starts Trading ADS on Nasdaq

27.02.19|Lilach Baumer
The Tel Aviv-listed medical diagnosis company received SEC approval for listing its ADS on the American exchange
שמעון אלון מנכ"ל אטיוניטי

Attunity CEO Talks Up Qlik Deal

24.02.19|Tzally Greenberg
On Thursday, Attunity announced a deal to be acquired by data analytics company Qlik for $560 million
הדוגמנית קרלי קלוס היא פרזנטורית של ויקס

Wix Beats Analyst Consensus on Quarterly, Annual Revenues

20.02.19|Lilach Baumer
The Israeli website building company closed 3.48% up on Nasdaq Tuesday
אודי מוקדי מנכ"ל מייסד סייברארק

CyberArk Revenues Up 31% in 2018

17.02.19|Hezi Sternlicht
The information security company reported $109.1 million in revenue for the fourth quarter of 2018, up 36% year over year and exceeding analysts’ expectations of $95.94 million
אייל ולדמן מלאנוקס

Starboard Cuts Stake as Mellanox Peaks

17.02.19|Golan Hazani
The activist investor sold 28% of its holdings in the Israeli chipmaker over the past week, taking advantage of Mellanox’s stock reaching its highest valuation since 2012